+227.4%
HUT vs GSK
+24.6%
+202.8%
-41.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.6% | +0.2% | -3.8% | -3.5% |
| 7D | +18.9% | -3.6% | +22.5% | +17.3% |
| 30D | +12.0% | -5.9% | +17.9% | +9.8% |
| 3M | -14.9% | -4.3% | -10.6% | -15.9% |
| 6M | +96.8% | -10.8% | +107.6% | +90.8% |
| YTD | +108.8% | +1.8% | +107.0% | +124.9% |
| 1Y | +227.4% | +23.5% | +203.9% | +266.2% |
| All | +227.4% | +24.6% | +202.8% | +266.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling